Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Diagnostic Value of C-reactive Protein for Detection of Postoperative Inflammatory Complications After Gastroesophageal Cancer Surgery

This study has been completed.
Information provided by:
Cantonal Hospital of St. Gallen Identifier:
First received: November 29, 2010
Last updated: December 9, 2010
Last verified: November 2010
Although widely used, there is a lack of evidence concerning diagnostic value of C-reactive protein (CRP) in the postoperative course. The aim of this study was to evaluate the diagnostic accuracy of CRP for postoperative inflammatory complications after gastroesophageal cancer.

Condition Intervention
Given Indication for Gastroesophageal Cancer Surgery
Other: gastroesophageal cancer surgery

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective

Resource links provided by NLM:

Further study details as provided by Cantonal Hospital of St. Gallen:

Primary Outcome Measures:
  • postoperative Inflammatory complications [ Time Frame: 30 days postoperatively ] [ Designated as safety issue: No ]

Estimated Enrollment: 200
Study Start Date: December 2010
Study Completion Date: December 2010
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Patients after gastroesophageal cancer surgery Other: gastroesophageal cancer surgery
gastroesophageal cancer surgery


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Given indication for gastroesophageal cancer surgery

Inclusion Criteria:

  • all patients with gastroesophageal cancer surgery

Exclusion Criteria:

  • lack of measurement of C-reactive protein
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01249534

Department of surgery
St. Gallen, Switzerland, 9007
Sponsors and Collaborators
Cantonal Hospital of St. Gallen
Principal Investigator: Rene Warschkow, MD Cantonal Hospital St. Gallen
  More Information

Responsible Party: Rene Warschkow, MD, Kantonal Hospital St. Gallen, Department of Visceral Surgery Identifier: NCT01249534     History of Changes
Other Study ID Numbers: EKSG10/144 
Study First Received: November 29, 2010
Last Updated: December 9, 2010
Health Authority: Switzerland: Ethikkommission processed this record on October 25, 2016